Kimberlee C Drapkin - Net Worth and Insider Trading

Kimberlee C Drapkin Net Worth

The estimated net worth of Kimberlee C Drapkin is at least $124,114 dollars as of 2024-05-12. Kimberlee C Drapkin is the CFO and Treasurer of Jounce Therapeutics Inc and owns about 66,018 shares of Jounce Therapeutics Inc (JNCE) stock worth over $124,114. Details can be seen in Kimberlee C Drapkin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kimberlee C Drapkin has not made any transactions after 2023-01-10 and currently still holds the listed stock(s).

Transaction Summary of Kimberlee C Drapkin

To

Kimberlee C Drapkin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kimberlee C Drapkin owns 6 companies in total, including Jounce Therapeutics Inc (JNCE) , Proteostasis Therapeutics Inc (PTI) , and Yumanity Therapeutics Inc (YMTX) among others .

Click here to see the complete history of Kimberlee C Drapkin’s form 4 insider trades.

Insider Ownership Summary of Kimberlee C Drapkin

Ticker Comapny Transaction Date Type of Owner
JNCE Jounce Therapeutics Inc 2023-01-10 CFO and Treasurer
PTI Proteostasis Therapeutics Inc 2020-06-29 director
YMTX Yumanity Therapeutics Inc 2021-06-02 director
2022-04-01 director
2021-06-02 director
2023-07-28 director

Kimberlee C Drapkin Latest Holdings Summary

Kimberlee C Drapkin currently owns a total of 1 stock. Kimberlee C Drapkin owns 66,018 shares of Jounce Therapeutics Inc (JNCE) as of January 10, 2023, with a value of $124,114.

Latest Holdings of Kimberlee C Drapkin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JNCE Jounce Therapeutics Inc 2023-01-10 66,018 1.88 124,114

Holding Weightings of Kimberlee C Drapkin


Kimberlee C Drapkin Form 4 Trading Tracker

According to the SEC Form 4 filings, Kimberlee C Drapkin has made a total of 8 transactions in Jounce Therapeutics Inc (JNCE) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Jounce Therapeutics Inc is the sale of 14,096 shares on January 10, 2023, which brought Kimberlee C Drapkin around $15,647.

Insider Trading History of Kimberlee C Drapkin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kimberlee C Drapkin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kimberlee C Drapkin Ownership Network

Ownership Network List of Kimberlee C Drapkin

No Data

Ownership Network Relation of Kimberlee C Drapkin


Kimberlee C Drapkin Owned Company Details

What does Jounce Therapeutics Inc do?

Who are the key executives at Jounce Therapeutics Inc?

Kimberlee C Drapkin is the CFO and Treasurer of Jounce Therapeutics Inc. Other key executives at Jounce Therapeutics Inc include 10 percent owner Concentra Merger Sub, Inc. , 10 percent owner Concentra Biosciences, Llc , and director & CEO and President Richard /ca/ Murray .

Jounce Therapeutics Inc (JNCE) Insider Trades Summary

Over the past 18 months, Kimberlee C Drapkin made 1 insider transaction in Jounce Therapeutics Inc (JNCE) with a net sale of 14,096. Other recent insider transactions involving Jounce Therapeutics Inc (JNCE) include a net sale of 84,298 shares made by Richard /ca/ Murray , a net purchase of 85,987 shares made by Kevin C Tang , and a net sale of 16,634 shares made by Hugh M Cole .

In summary, during the past 3 months, insiders sold 0 shares of Jounce Therapeutics Inc (JNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 124,313 shares of Jounce Therapeutics Inc (JNCE) were sold and 85,987 shares were bought by its insiders, resulting in a net sale of 38,326 shares.

Jounce Therapeutics Inc (JNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jounce Therapeutics Inc Insider Transactions

No Available Data

Kimberlee C Drapkin Mailing Address

Above is the net worth, insider trading, and ownership report for Kimberlee C Drapkin. You might contact Kimberlee C Drapkin via mailing address: Predix Pharmaceuticals Holdings, Inc., 4 Maguire Road, Lexington Ma 02421.

Discussions on Kimberlee C Drapkin

No discussions yet.